AU2015201426B2 — Process for the preparation of 4- {4-[({[4 -chloro-3 -(trifluoromethyl)-phenyl]amino} carbonyl)amino]-3-fluorophenoxy}-N-methylpyridine-2-carboxamide, its salts and monohydrate
Assigned to Bayer Healthcare LLC · Expires 2016-07-07 · 10y expired
What this patent protects
H:\grs\Intrwovn\NRPortbl\DCC\GRS\747491 I L.docx-17/03/2015 PROCESS FOR THE PREPARATION OF 4-{4-[({[4-CHLORO-3 (TRIFLUOROMETHYL)-PHENYL]AMNO}CARBONYL)AMINO]-3 FLUOROPHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE, ITS SALTS AND MONOHYDRATE The present invention relates to a process for p…
USPTO Abstract
H:\grs\Intrwovn\NRPortbl\DCC\GRS\747491 I L.docx-17/03/2015 PROCESS FOR THE PREPARATION OF 4-{4-[({[4-CHLORO-3 (TRIFLUOROMETHYL)-PHENYL]AMNO}CARBONYL)AMINO]-3 FLUOROPHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE, ITS SALTS AND MONOHYDRATE The present invention relates to a process for preparing 4-{4-[({[4-chloro-3-(trifluoromethyl) phenyl] amino I carbonyl)amino] -3 -fluorophenoxy I -N-methylpyridine-2-carboxamide, its salts and monohydrate.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.